Chan, Adelyne S. L. https://orcid.org/0000-0003-2214-0306
Zhu, Haoran https://orcid.org/0000-0003-3879-0389
Narita, Masako https://orcid.org/0000-0002-9774-4908
Cassidy, Liam D.
Young, Andrew R. J. https://orcid.org/0000-0002-7522-5525
Bermejo-Rodriguez, Camino https://orcid.org/0000-0002-7554-1640
Janowska, Aleksandra T. https://orcid.org/0009-0005-3104-3542
Chen, Hung-Chang
Gough, Sarah https://orcid.org/0000-0001-8697-9659
Oshimori, Naoki
Zender, Lars https://orcid.org/0000-0001-7626-2849
Aitken, Sarah J. https://orcid.org/0000-0002-1897-4140
Hoare, Matthew https://orcid.org/0000-0001-5990-9604
Narita, Masashi https://orcid.org/0000-0001-7764-577X
Article History
Received: 20 April 2023
Accepted: 5 July 2024
First Online: 7 August 2024
Competing interests
: M.H. has received an unrestricted research grant from Pfizer and consults for AstraZeneca, Boston Scientific and Quotient Therapeutics. All of the other authors declare no competing interests.